| scholarly article | Q13442814 |
| P50 | author | Natale Daniele Brunetti | Q43964699 |
| P2093 | author name string | Antonio Totaro | |
| Deodata Montrone | |||
| Matteo Di Biase | |||
| Michele Correale | |||
| Riccardo Ieva | |||
| Anna Rita Russo | |||
| Anna Maria Fanigliulo | |||
| P2860 | cites work | Beneficial effects of statins on endothelial dysfunction and vascular stiffness | Q80603709 |
| Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells | Q28379577 | ||
| Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) | Q31106778 | ||
| Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. | Q31942216 | ||
| Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction | Q33331962 | ||
| Atorvastatin and statins in the treatment of heart failure | Q37000767 | ||
| Observational studies of statins in systolic heart failure | Q37146703 | ||
| Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy | Q37149829 | ||
| Proinflammatory cytokines in heart failure: double-edged swords | Q37734294 | ||
| Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention | Q37761342 | ||
| Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis | Q38377634 | ||
| Circulating interleukin-10: association with higher mortality in systolic heart failure patients with elevated tumor necrosis factor-alpha | Q42947172 | ||
| Do statins improve heart failure outcome in post-myocardial infarction patients with moderate to severe left ventricular dysfunction? | Q42956283 | ||
| The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy. | Q43234015 | ||
| The effects of initiation or continuation of statin therapy on cholesterol level and all-cause mortality after the diagnosis of left ventricular systolic dysfunction. | Q44134919 | ||
| Relation of statin therapy to risk of heart failure after acute myocardial infarction. | Q44405712 | ||
| Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus | Q44624216 | ||
| Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells | Q44712590 | ||
| Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation. | Q45918160 | ||
| Inflammatory mediators in Chinese patients with congestive heart failure. | Q46034422 | ||
| Amplitudes, durations, and timings of apically directed left ventricular myocardial velocities: I. Their normal pattern and coupling to ventricular filling and ejection | Q46341098 | ||
| Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging. | Q46411429 | ||
| Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study | Q46489522 | ||
| Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity | Q46675314 | ||
| Systolic time intervals revisited: correlations with N-terminal pro-brain natriuretic peptide in a community population | Q46825434 | ||
| Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: a 1-year follow-up study | Q48446603 | ||
| Systolic time intervals as simple echocardiographic parameters of left ventricular systolic performance: correlation with ejection fraction and longitudinal two-dimensional strain. | Q50697633 | ||
| Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique | Q73902318 | ||
| Tissue Doppler echocardiographic evidence of reverse remodeling and improved synchronicity by simultaneously delaying regional contraction after biventricular pacing therapy in heart failure | Q77559124 | ||
| Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT | Q79268881 | ||
| P433 | issue | 5 | |
| P921 | main subject | heart failure | Q181754 |
| statin therapy | Q62562875 | ||
| P304 | page(s) | 777-784 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Clinics | Q26841864 |
| P1476 | title | Statin therapy blunts inflammatory activation and improves prognosis and left ventricular performance assessed by Tissue Doppler Imaging in subjects with chronic ischemic heart failure: results from the Daunia Heart Failure Registry | |
| P478 | volume | 66 |
| Q37311952 | A prospective, randomized study: Evaluation of the effect of rosuvastatin in patients with chronic obstructive pulmonary disease and pulmonary hypertension |
| Q41959819 | Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts |
| Q41994619 | Cardiopulmonary exercise test predicts sustained ventricular arrhythmias in chronic heart failure. |
| Q43138120 | Cardiovascular research in CLINICS. |
| Q89620715 | Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy |
| Q64282792 | Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry |
| Q90095047 | Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry |
| Q38166321 | Statin therapy in heart failure: for good, for bad, or indifferent? |
| Q36811609 | The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up |
| Q26822921 | Tissue Doppler imaging in coronary artery diseases and heart failure |
| Q37114576 | Treatment with atorvastatin is associated with a better prognosis in chronic heart failure with systolic dysfunction: results from The Daunia Heart Failure Registry. |
Search more.